| INTRODUC TI ON
Hyaluronan (HA) is a naturally occurring non-sulfated glycosaminoglycan involved in maintaining extracellular matrix (ECM) resilience and tissue hydration. HA is present in various body fluids such as synovial fluid, serum, saliva, and gingival crevicular fluid [1] [2] [3] as well as in mineralized and non-mineralized tissues, including the periodontium. 4 Higher amounts of HA are detected in gingiva and periodontal ligament 5 than in cementum 6 and alveolar bone. 7 Due to its hygroscopic and viscoelastic properties as well as high conservation among species, HA has been utilized in a number of biomedical applications in dermatology, ophthalmology, osteoarthritis treatment, oral and maxillofacial surgery as well as in various tissue engineering applications. 8 Although HA is involved in many different biological processes during tissue repair and regeneration, detailed mechanisms of action especially in oral soft tissue wound healing following periodontal regenerative procedures remain largely uncovered.
During wound healing, HA exhibits differential effects based on its molecular weight (MW). 9 In early stages, there is a sharp increase in high MW (>1000 kDa) HA, which has the ability to bind fibrinogen, a reaction intrinsic to clot formation. 10 The initial large HA polymer is anti-angiogenic and immunosuppressive, facilitating polymorphonuclear leukocyte access to the wound site for removal of dead tissue, debris and bacteria. Thereafter, in the inflammatory stage, HA fragments of lower MW (<700 kDa) accumulate due to hyaluronidase activity or oxidation. 11 These are able to induce production of pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and IL-8 12 as well as angiogenesis.
13
In periodontal wound healing in particular, HA has been shown to induce production of pro-inflammatory cytokines by fibroblasts, keratinocytes, cementoblasts, and osteoblasts, which promotes the inflammatory response and consequently stimulates hyaluronan synthesis by endothelial cells.
14
The wound healing process involves a number of events rigorously controlled by matrix metalloproteinases (MMPs) and growth factors including transforming growth factor-β1 (TGF-β1), plateletderived growth factor (PDGF), fibroblast growth factor-2 (FGF-2), and epidermal growth factor (EGF). 15 MMPs degrade ECM components and elicit a pro-inflammatory response, thus promoting cell migration during wound remodeling. 16 PDGF induces cellular responses throughout all phases of the repair process. 17 TGF-β1 has been recognized as a key regulator of collagen expression. 18 FGF-2 plays a role in re-epithelialization, angiogenesis, and granulation tissue formation but also contributes to matrix synthesis and remodeling, which are critical for the wound healing process. 19 Similarly, EGF is a potent stimulator of epithelialization, angiogenesis, fibroblast proliferation, and survival.
20
A number of studies describe the use of exogenous HA in nonsurgical and surgical periodontal therapy with generally beneficial but moderate effects on surrogate outcome variables of periodontal inflammation, ie, bleeding on probing and residual pocket depth. 21, 22 However, only few studies exist on the use of HA in reconstructive periodontal surgery. 
| Cell proliferation assay
Proliferation rates of HA-treated HPF or HGF cells were determined using a 5-bromo-20-deoxyuridine (BrdU) incorporation assay (Roche, Basel, Switzerland) as described. 27 
| Cell migration assay
Cell migration was assayed using transwell polycarbonate mem- 
| qRT-PCR
Quantitative RT-PCR was used to investigate the expression of COL1A1, COL3A1, TGFB1, TGFB3, PDGFB, FGF2, EGF, IL1A, IL1B, TNF, MMP1, 2, 3, and 8 genes. Total RNA from HA-or growth factortreated cells was isolated using the RNeasy Mini Kit (Qiagen, Basel, Switzerland). RNA was reverse transcribed and relative transcripts for the above genes, normalized to GAPDH, were measured using FastStart Universal SYBR Green Master ROX (Roche) and the primer sequences listed in Table S1 . Real-time PCR was carried out in a 7500
Real-Time PCR System (Applied Biosystems, Foster City, CA, USA).
Data were analyzed using the efficiency ∆∆Ct method. 29 All samples were run in duplicates. Data represent means ± SD from three independent experiments performed with three different cell donors.
| Immunoblotting
Whole-cell extracts from HA-treated HPF and HGF cells were prepared by lysis in RIPA buffer as described. 30 Lysates were run on 10% SDS-PAGE, and transferred to Amersham 
| Statistical analysis
All grouped data are means ± SD. Differences between groups were assessed by one-way analysis of variance (ANOVA) with Tukey's post hoc test using GraphPad InStat Software, version 3.05. Values of P < 0.05 were considered statistically significant.
| RE SULTS

| The two HA preparations exert no negative effects on the viability of primary HPF and HGF cells
Coating of cell culture plates with HA1 resulted in the formation of a continuous uniform gel layer onto which both cell types, HPF and HGF, were able to adhere and assumed a fibroblast-specific spindle-shaped morphology that did not differ from the morphology of untreated cells seeded on non-coated cell culture plastic ( Figure S1 ). In contrast, coating with HA2 resulted in the formation of HA meshes, most likely due to HA2 being cross-linked to BDDE. Thus, cells appeared to adhere solely on the cell culture plastic while HA2 was present in suspension ( Figure S1 ). Due to the observed difference in the natural occurrence of the two HAs, a further distinction between HA applied as a coating or in suspension was not made and we referred to "HA treatment" throughout the study.
We first compared the effects of the two HA preparations on HPF and HGF cell viability. Relative to control cells (0 mg/mL HA; 100% cell viability), fibroblasts exposed to HA1 or HA2 at various concentrations (0-4 mg/mL) maintained a high level of viability (≥100%; Figure 1A ).
F I G U R E 1 Effects of hyaluronan (HA) preparations on the metabolism and behavior of primary human palatal (HPF) and gingival (HGF) fibroblasts. A, The two HA preparations exert no negative effects on the viability of primary oral fibroblasts. Viability of HPF and HGF cells incubated with various concentrations (0-4 mg/mL) of each of the two HA preparations was assessed by measuring the metabolic capacity using the CellTiter-Blue ® Cell Viability Assay. Viable cells retain the ability to reduce the indicator dye resazurin into highly fluorescent resorufin. Experimental values were normalized to those of control cells (0 mg/mL HA; 100% viability). Data represent means ± SD from three independent experiments. B and C, The two HA preparations strongly increase the proliferative and migratory abilities of primary oral fibroblasts. B, Proliferation rates of HA-treated HPF and HGF cells were assessed by BrdU incorporation into newly synthesized DNA immediately after plating (0 h) as well as at 24, 48, 72, and 96 h. Means ± SD from three independent experiments and significant differences to control (ctrl) cells at the time point 0, ***P < 0.001, **P < 0.01 are shown. C, Migration of HPF and HGF cells toward HA was evaluated by transwell migration assay using filters with 8 μm pore size. Cell migration was quantified by measuring the area on the lower side of the filter covered with cells. Means ± SD from three independent experiments and significant differences to control cells, ***P < 0.001, **P < 0.01 are shown. Representative images of the staining in each of the experimental groups are shown below the bar graph. Scale bar, 500 μm Data represent means ± SD from three independent experiments. Significant differences to the respective control unless otherwise indicated, ***P < 0.001, **P < 0.01, *P < 0.05
Next, we examined the migratory capacity of oral fibroblasts toward HA using a transwell assay. Similarly to the effect on cellular proliferation, each of the two HA preparations significantly induced fibroblast cell migration by 6-9-fold compared to control cells (P < 0.01; Figure 1C ).
Taken together, these results showed a strong pro-proliferative and pro-migratory effect of HA on primary oral fibroblasts with no significant differences in the potency between the two HA formulations.
| The two HA preparations trigger expression of COL3A1 and TGFB3 genes characterizing scarless wound healing
Invasion and proliferation of fibroblasts at the defect site precedes collagen deposition. Thus, we next studied the effect of the HA preparations on the expression of type I and type III collagens in the primary oral fibroblasts (Figure 2A and B) . Accumulation of type I collagen is enhanced in scars and fibrosis, whereas type III collagen is abundant during fetal development and scarless fetal wound healing. 31 Interestingly, compared to untreated control cells, either HA preparation upregulated the expression levels of COL3A1 in both HPFs and HGFs at 24 hour ( Figure 2B ), whereas no effect on COL1A1 mRNA levels was detected (Figure 2A ).
We further determined the influence of the HA preparations on the expression of TGFB1 and TGFB3 ( Figure 2C and D) , two TGF-β isoforms that play critical roles in wound healing by modulating ECM formation. Whereas TGF-β1 is generally known as pro-fibrotic, TGF-β3 is the isoform that predominates in scarless fetal wound healing. 32 Interestingly, both HAs caused a significant increase in TGFB3 mRNA levels compared to control fibroblasts F I G U R E 3 Hyaluronan (HA) induces expression of genes encoding growth factors and cytokines essential for the wound healing process in primary human palatal (HPF) and gingival (HGF) fibroblasts. Effect of HA1 and HA2 on PDGFB (A), FGF2 (B), EGF (C), IL1A (D), IL1B (E), and TNF (F) mRNA levels in HPF and HGF cells. Oral fibroblasts were treated with each of the two HA preparations for 24 h before total RNA was extracted and analyzed by qRT-PCR. Values normalized to GAPDH are expressed relative to the values of untreated control (ctrl) cells. Data represent means ± SD from three independent experiments. Significant differences to the respective control unless otherwise indicated, ***P < 0.001, **P < 0.01, *P < 0.05 ( Figure 2D ), whereas the expression of TGFB1 was unchanged ( Figure 2C ). Furthermore, in both cell types, HA1 appeared to be more potent (by 2-fold, P < 0.001) than HA2 in inducing TGFB3 expression ( Figure 2D ).
These results indicated that both HAs favor the expression of genes characteristic of scarless vs pro-fibrotic wound healing.
| HA induces expression of genes encoding growth factors and cytokines involved in wound healing in primary HPF and HGF cells
Growth factors such as PDGFB, FGF-2 and EGF stimulate the proliferation and migration of human gingival fibroblasts in a dosedependent manner. 
| HA induces cell type-specific differences in the expression of MMP2 and MMP3 genes
During oral wound healing, the granulation tissue ECM is continuously remodeled by MMPs, most notably collagenases MMP-1 and 8, major gelatinase MMP-2, and stromelysin-1 (MMP-3). Figure 4D ).
Thus, we observed cell type-specific differences in the expression of two of the four MMPs tested upon HA treatment.
| Pro-inflammatory cytokines exhibit a stimulatory and dose-dependent effect on MMP2 and MMP3 gene expression in primary HPF and HGF cells
The pro-inflammatory cytokines IL-1α, IL-1β, and TNF-α are known to play a major role in regulating MMP expression in different fibroblast cell lines and inflammatory diseases. 
| The two HA preparations significantly enhance phosphorylation of Akt, Erk1/2 and p38 kinases in primary oral fibroblasts
To gain insights into the mechanisms whereby the two HAs exert their effects on gene expression in primary oral fibroblasts, we investigated the activation state of signaling kinases that might be triggered by HA.
We focused on the activation of PI3-kinase/Akt, Erk1/2, and p38, because HA has been reported to stimulate these pathways in other systems. 9 Compared to the basal levels of phospho-Akt, phospho- Data represent means ± SD from three independent experiments. Significant differences to the respective control unless otherwise indicated, ***P < 0.001, **P < 0.01, *P < 0.05
| D ISCUSS I ON
Palatal and gingival fibroblasts play an important role in oral wound healing. The use of bioactive substances that influence their behavior and thus support oral soft tissue wound healing/regeneration is of major clinical interest. Therefore, the aim of the present study was to investigate the specific role of two commercially available HA formulations in affecting oral fibroblast cell behavior, F I G U R E 5 Pro-inflammatory cytokines exhibit a stimulatory and dose-dependent effect on MMP2 and MMP3 gene expression in primary human oral fibroblasts. Effect of recombinant IL-1α, IL-1β, andTNF-α on the expression of MMP genes in primary human palatal (HPF) and gingival (HGF) fibroblasts. Cells were treated with increasing concentrations (0, 5, and 10 ng/mL) of each of the three proinflammatory cytokines for 24 h before total RNA was extracted. Expression of MMP1 (A), MMP8 (B), MMP2 (C), and MMP3 (D) mRNAs was analyzed by qRT-PCR. Values normalized to GAPDH are expressed relative to the values of untreated cells (0 ng/mL HA). Means ± SD from three independent experiments and significant differences to untreated cells, ***P < 0.001, **P < 0.01, *P < 0. The effect of HA on cell proliferation in vitro is known to be closely related to its MW and concentration. 22 Low MW HA was reported to increase cell proliferation in studies with rat and mouse mesenchymal stem cells, 43, 44 rabbit bone marrow-derived stem cells 45 as well as in an organotypic keratinocyte-fibroblast co-culture model. 46 In contrast, the reported effects of high MW HA on cellular proliferation are controversial. 22 A significant stimulatory as well as an inhibitory effect has been seen dependent on the cellular context, HA concentrations, and method of delivery of HA to the cell culture.
F I G U R E 6
The two hyaluronan (HA) preparations significantly enhance phosphorylation of Akt, Erk1/2, and p38 kinases in primary human oral fibroblasts.
Immunoblot analyses of phospho-Akt (pAkt) (A), phospho-Erk1/2 (pErk1/2) (B), and phospho-p38 (pp38) (C) proteins in whole-cell extracts from HA-treated primary human palatal (HPF) and gingival (HGF) fibroblasts. Blots for total Akt, Erk1/2, and p38 proteins as well as the vinculin loading control are also shown. The bar charts represent densitometric quantifications of the immunoblots. pAkt, pErk1/2, and pp38 levels are normalized to the respective total proteins used as internal controls. Data represent means ± SD from three independent experiments. Significant differences to the respective control (ctrl) cells of each of the two cell types, **P < 0.01, *P < 0.05
Here, we report a strong positive effect of both HA preparations on HPF and HGF cell proliferation. In addition to the pro-proliferative effect, we observed a significantly enhanced migratory ability of oral fibroblasts toward HA. The HA-induced cell motility might be due to 
54
The high abundance of HA in amniotic fluid and embryonic tissues and its involvement in a mechanism that supports scarless repair in the fetus are well documented. 55 Here, we report an upregulation of COL3A1 and TGFB3 gene expression in HA-treated oral fibroblasts, suggesting that the HAs tested in our study might contribute to the generation of a fetal-like cell environment that favors scarless healing. Thus, HA might appear particularly important in the early stages of wound repair when ECM deposition needs to be limited.
Exogenous high MW-HA has been shown to be antiinflammatory, eg, in a T cell-mediated liver injury model in mice 56 or in fibroblast-like synoviocytes in a human osteoarthritis model. 57 On contrary, we observed an increased expression of pro-inflammatory cytokines in oral fibroblasts treated with each of the two high MW-HAs. Others have also shown that high MW-HA stimulates production of IL-1β, TNF-α, and IL-8 in human uterine fibroblasts. 12 These contradictions might be related to the specific HA formulations as well as the cellular context used. However, as an inflammatory reaction is generally indispensable for the kick-off of wound repair, the pro-inflammatory effect of the HA preparations tested in the current study might appear clinically beneficial especially when the HAs are applied on non-inflamed tissues during plastic-esthetic periodontal surgery. Furthermore, it has been shown that the pro-inflammatory cytokines IL-1α, IL-1β, and TNF-α play a major role in regulating MMP expression in different cell types. 35, [58] [59] [60] [61] [62] [63] The effects of the pro-inflammatory cytokines on MMP expression appear to depend greatly on the cellular context. It has been reported that IL-1α upregulates MMP1 and 3 mRNA and protein expression in dental pulp fibroblasts, thus inducing collagen degradation and pulp destruction. 60 Furthermore, expression of MMP1, 2, and 3 in dental pulp fibroblasts was also stimulated by IL-1β and TNF-α. 59 In contrast, Dasu 
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